advanced search

<< Back To Home

- - - WHAT'S NEW THIS FRIDAY: PARENTAL ACCEPTANCE OF HPV VACCINATIONIN INDONESIA

Thursday, 28th of March 2013

• PARENTAL ACCEPTANCE OF HUMAN PAPILLOMAVIRUS (HPV) VACCINATION IN INDONESIA: A CROSS-SECTIONAL STUDY.

 

Vaccine. 2011 Oct 13;29(44):7785-93. doi: 10.1016/j.vaccine.2011.07.107. Epub 2011 Aug 5.

Jaspers L, Budiningsih S, Wolterbeek R, Henderson FC, Peters AA.

Source

Leiden University Medical Center, Department of Gynaecology & Obstetrics, Postzone K-06-P16, P.O. Box 9600, 2300 RC Leiden, The Netherlands. loesjaspers@gmail.com

Abstract below; full text available to journal subscribers

BACKGROUND:

Cervical cancer ranks the second most frequent cancer in Indonesian women. In Indonesia, human papillomavirus (HPV) vaccine acceptance has not been studied before.

OBJECTIVE:

To determine parental HPV vaccine acceptance in Indonesia, and factors that influence their decision. Factors include sociodemographic factors, knowledge of HPV, HPV vaccination and cervical cancer, health beliefs about cervical cancer, and attitudes towards vaccination in general.

METHODS:

746 parents, with at least 1 daughter aged 0-14, were interviewed using questionnaires based on published and adjusted interviews. Interviews were done in sub district public health centers, general governmental hospitals, and via house-visits, in 5 Indonesian provinces.

RESULTS:

Parental HPV vaccine acceptance was 96.1%. Logistic regression revealed that age, beliefs regarding cervical cancer, and attitudes towards vaccination in general were significantly associated with HPV vaccine acceptance. Of the participants, 66.0%, 16.6%, and 15.8% had heard about cervical cancer, HPV, and HPV vaccination respectively. The mean total knowledge score was 1.91(Standard Deviation 2.31) on a 0-8 scale. Health beliefs about cervical cancer and attitudes towards vaccination in general were positive. Participants named the high cost of the vaccine, fear for side-effects, and chosen vaccination locations as possible barriers towards HPV vaccine implementation.

DISCUSSION:

Parental HPV vaccine acceptance is high, but knowledge about HPV and cervical cancer is low. During HPV vaccination programs, focus should not only be on providing information, but also on existing beliefs and attitudes towards cervical cancer and vaccination in general. If HPV vaccination programs were to be implemented in Indonesia, the indicated barriers should be taken into account.

Copyright © 2011 Elsevier Ltd. All rights reserved.

 

 

• PROVIDER PERCEPTIONS OF BARRIERS AND FACILITATORS OF HPV VACCINATION IN A HIGH-RISK COMMUNITY

Vaccine. 2012 Jun 22;30(30):4511-6. doi: 10.1016/j.vaccine.2012.04.062. Epub 2012 May 3.

 

Javanbakht M, Stahlman S, Walker S, Gottlieb S, Markowitz L, Liddon N, Plant A, Guerry S.

Source

Department of Epidemiology, University of California, Los Angeles, Box 951772, Los Angeles, CA 90095-1772, USA. javan@ucla.edu

Abstract below; full text available to journal subscribers

BACKGROUND:

Maximizing HPV vaccine uptake among those at highest risk for cervical cancer is critical. We explored healthcare provider perspectives on factors influencing HPV vaccination among adolescent girls in a community with high cervical cancer rates.

METHODS:

From March to May 2009, we conducted in-depth interviews with 21 medical staff providing care to adolescent girls at two clinics in Los Angeles, CA, serving a predominantly Hispanic population with high cervical cancer rates. Interviews were recorded and transcribed data were reviewed for coding and thematic content related to potential barriers and facilitators of HPV vaccination.

RESULTS:

Providers and medical staff overwhelmingly focused on parental beliefs as barriers to HPV vaccination. Perceived parental misconceptions acting as barriers included the belief that adolescents do not need vaccinations and that no-cost vaccine programs like Vaccines for Children are only available for younger children. Perceived parental concerns that the vaccine will promote sexual activity were prevalent, which prompted providers to frame HPV vaccine as a "routine" vaccine. However, the medical staff felt mothers with a friend or relative supportive of HPV vaccination were more likely to request the vaccine. The staff also noted that for Hispanic parents the "preferred" source of information is peers; if the "right people" in the community were supportive of HPV vaccine, parents were more willing to vaccinate. Other barriers included lack of immunization records among immigrant parents and a difficult-to-reach, mobile clientele.

CONCLUSIONS:

Providers noted a number of barriers to HPV vaccination, including some perceived parental misconceptions that could be addressed with education about the need for adolescent vaccines and available free vaccine programs. Because community support appears particularly important to Hispanic parents, the use of promotoras - peer liaisons between health organizations and the community - may increase HPV vaccine uptake in this population.

Copyright © 2012 Elsevier Ltd. All rights reserved.